| 國立臺灣大學 |
2010 |
Cyp2c19 Genotypes in the Pharmacokinetics/Pharmacodynamics of Proton Pump Inhibitor-Based Therapy of Helicobacter Pylori Infection
|
楊智欽; 林君榮; YANG, JYH-CHIN; LIN, CHUN-JUNG |
| 臺大學術典藏 |
2018-09-10T08:02:38Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
Yang, J.-C.;Lin, C.-J.; CHUN-JUNG LIN; JYH-CHIN YANG |
| 臺大學術典藏 |
2021-06-04T03:09:19Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
Yang J.-C.; CHUN-JUNG LIN |
| 臺大學術典藏 |
2022-03-04T08:22:49Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J. |
| 臺大學術典藏 |
2021-05-27T02:50:13Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J. |
| 義守大學 |
2014-11 |
CYP2C19 polymorphism influences Helicobacter pylori eradication
|
Chao-Hung Kuo;Chien-Yu Lu;Hsiang-Yao Shih;Chung-Jung Liu;Meng-Chieh Wu;Huang-Ming Hu;Wen-Hung Hsu;Fang-Jung Yu;Deng-Chyang Wu;Fu-Chen Kuo |
| 臺大學術典藏 |
2020-03-09T04:23:59Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.;Nai-Chen Cheng;Tai H.;Jimmy Juang J.;Wu C.;Lin L.;Hwang J.;Lin J.;Chiang F.;Tsai C.; Lee J.; NAI-CHEN CHENG; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2020-12-04T07:44:32Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; LIAN-YU LIN; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2020-12-30T08:47:32Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Jimmy Juang J.; Cheng N.; Tai H.; Lee J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; CHIA-TI TSAI |
| 臺大學術典藏 |
2019 |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Wu C.; Tai H.; Jimmy Juang J.; Cheng N.; Lee J.; Lin L.; HWANG, JUEY-JEN; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2022-03-07T07:05:30Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
JEN-KUANG LEE; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2021-03-11T04:29:15Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.;Cheng N.;Tai H.;Jimmy Juang J.;Wu C.;Lin L.;Hwang J.;Lin J.;Fu-Tien Chiang;Tsai C.; Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; FU-TIEN CHIANG; Tsai C. |
| 臺大學術典藏 |
2020-12-02T11:04:26Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Tsai C.; Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; CHO-KAI WU; Lin L.; Hwang J.; Lin J.; Chiang F. |
| 臺大學術典藏 |
2022-09-06T02:41:27Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; LIAN-YU LIN; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2022-09-20T06:48:37Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; HWANG, JUEY-JEN; Lin J.; Chiang F.; Tsai C. |
| 國立臺灣大學 |
2008 |
CYP2C19基因多型性對短療程rabeprazole三合一療法之藥動/藥效關係及療效影響之評估
|
楊喻帆; Yang, Yu-Fan |
| 高雄醫學大學 |
2010 |
CYP2C19基因多型性對第一線幽門桿菌除菌治療的影響-比較四種PPI的處方
|
郭昭宏;王聖雯;翁碧娟;賴俊煌;黃耀康;吳登強 |
| 高雄醫學大學 |
2008 |
CYP2C19基因多型性與抗生素抗藥性在levofloxacin為主的救援療法扮演關鍵的角色
|
許文鴻;郭昭宏;郭富珍;吳宜真;陳君豪;許秉毅;陳和瑟;賴俊煌 |
| 國立臺灣大學 |
2006 |
Cyp2c9 Polymorphism and Warfarin Sensitivity in Taiwan Chinese
|
陳恆德; 翁祖輝; 鄭鈞文; CHERN, HERNG-DER; UENG, TZUU-HUEI; CHENG, CHUN-WEN |
| 國立臺灣大學 |
2006-12 |
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.
|
Chern, H.-D.; Ueng, T.-H.; Fu, Y.-P.; Cheng, C.-W. |
| 國立成功大學 |
1993 |
CYP2D 基因 C18 及 G4268 突變對藥品代謝的影響
|
黃金鼎 |
| 國立臺灣大學 |
2006 |
CYP2E1 AND XRCC1 GENETIC POLYMORPHISMS AND THE RISK OF LIVER FIBROSIS IN WORKERS EXPOSED TO VINYL CHLORIDE MONOMER
|
CHENG, TSUN-JEN; WANG, JUNG-DER; WONG, RUEY-HONG; HSIAO, TUN-JEN; 鄭尊仁; 王榮德; 翁瑞宏; 蕭敦仁 |
| 高雄醫學大學 |
2004 |
CYP2E1,GSTT1/M1基因多型性對職業苯暴露之尿中S-PMA生物偵測之影響
|
李曉雯;郭育良;廖寶琦;林隆晟;施政甫;莊弘毅;李姿瑜;黃奕孝;吳聰能;林雲卿;何啟功;石東生;張火炎 |
| 國立臺灣海洋大學 |
2005-02 |
CYP2K6 from zebrafish (Danio rerio): Cloning, mapping, developmental/tissue expression, and aflatoxin B1 activation by baculovirus expressed enzyme
|
J.L. Wang-Buhler;S.J. Lee;W.G. Chung;J.F. Stevens; H.P. Tseng;T.H. Hseu;C.H. Hu;M. Westerfield;Y.H. Yang;C.L. Miranda;D.R. Buhler |
| 國立成功大學 |
2011 |
CYP3A4基因調控及其受藥品與其他基因的影響
|
黃金鼎 |
